Publications by authors named "Weilei Hu"

Claim this Profile
T
TIL Therapy in Lung Cancer: Current Progress and Perspectives.
Weilei Hu, Yifei Bian, Hongbin Ji

Adv Sci (Weinh)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma.
Zheyi Wang, Yue Zhao, Yang Wo, Yizhou Peng, Weilei Hu, Chunnan Liu, Kan Huang, Hui Hong, Yihua Sun

Cancer Lett· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated mPD-L1 and metabolic analysis identifies new prognostic subgroups in lung cancers with wild-type EGFR.
Guosheng Wang, Weilei Hu, Yundi Chen, Yuan Wan, Qiang Li

Clin Transl Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade.
Weilei Hu, Guosheng Wang, Yian Wang, Matthew J Riese, Ming You

iScience· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
Miaowei Wu, Weilei Hu, Guosheng Wang, Yihan Yao, Xiao-Fang Yu

Front Genet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Methylome and Transcriptome Analyses Reveals Potential Therapeutic Targets for EGFR Wild Type Lung Cancers with Low PD-L1 Expression.
Weilei Hu, Guosheng Wang, Lonny B Yarmus, Yuan Wan

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
Weilei Hu, Guosheng Wang, Dongsheng Huang, Meihua Sui, Yibing Xu

Front Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coupled immune stratification and identification of therapeutic candidates in patients with lung adenocarcinoma.
Weilei Hu, Guosheng Wang, Yundi Chen, Lonny B Yarmus, Biao Liu

Aging (Albany NY)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy.
Guosheng Wang, Weilei Hu, Haiqiong Chen, Xin Shou, Tingting Ye

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation.
Xin Shou, Yong Li, Weilei Hu, Tingting Ye, Guosheng Wang, Meihua Sui

Mol Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging roles and therapeutic value of exosomes in cancer metastasis.
Miaowei Wu, Guosheng Wang, Weilei Hu, Yihan Yao, Xiao-Fang Yu

Mol Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review.
Shu Yang, Qi Lin, Wei Lin, Weilei Hu, Guosheng Wang

World J Surg Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis